Marc is known for his thoroughness, attention to detail and comprehensive understanding of all the issues in a case.
Marc is a partner in the intellectual property practice group of Bird & Bird. He is based in The Hague, and heads the life sciences group in the Netherlands.
With more than 19 years of experience, Marc specialises in patents and other intellectual property rights. He has in-depth knowledge of cross-border European patent litigation, particularly in the pharma and biotech industries. In pharma, Marc has litigated many patent cases concerning blockbuster drugs.
His practice also includes advising clients on their strategic preparations for the Unitary Patent Package (Unitary Patent and Unified Patent Court), and on complex multidisciplinary (IP-related) deals and disputes involving cutting edge technologies. His client-portfolio ranges from global pharmaceutical and chemical listed companies to universities and start-ups.
Apart from litigating before Dutch courts, he has also represented clients before the European Court of Justice.
Marc was admitted to the bar in 1996, and joined Bird & Bird in 2007. He is a member of several professional organisations, such as the International Trademark Association (INTA) and the International Association for the Protection of Intellectual Property (AIPPI). Furthermore, he is a member of the expert group (IP) of HollandBIO, the Dutch association for the biotech industry.
IAM Patent 1000 (2013) comments: "Widely touted for his pharmaceutical patent litigation skills, Marc Van Wijngaarden dispatches cross-border mandates with panache." The Legal 500: EMEA (2014) says: "Marc van Wijngaarden provides 'invaluable advice and representation'." Chambers Global (2014) states: "Marc van Wijngaarden engages in a significant amount of patent litigation, frequently on a cross-border basis."
This biography is an extract from Who's Who Legal: Life Sciences which can be purchased from our Shop.
Marc van Wijngaarden also features in the following practice areas:
It is not possible to buy entry into any Who's Who Legal publication
Nominees have been selected based upon comprehensive, independent survey work with both general counsel and private practice lawyers worldwide. Only specialists who have met independent international research criteria are listed.